Daily BriefsIndia

Daily Brief India: NIFTY Index, Anthem Biosciences, GNA Axles Ltd and more

In today’s briefing:

  • EQD / NSE NIFTY50 Vol Update / IVs Jump on HMPV Scare Then Grind Lower as Mkts Hold Support.
  • Anthem Biosciences Limited Pre-IPO Tearsheet
  • GNA Axles (INE934S01014): Steady Q3FY25 Earnings, Major Expansion and Sustainability Push


EQD / NSE NIFTY50 Vol Update / IVs Jump on HMPV Scare Then Grind Lower as Mkts Hold Support.

By Sankalp Singh

  • IVs jump early as sentiment soured, but trailed off through the week as underlying markets held support zones. Vol-Regime Model retains “High & Down” state.
  • Skew & Smile unchanged over the week in spite of the rollercoaster ride in IVs. Term-structure experienced to-and-fro swings.    
  • Trading Strategy Implications: Iron Condor/ Butterfly structures to be continued as long as regime model indicates “High & Down” vol state. 

Anthem Biosciences Limited Pre-IPO Tearsheet

By Nicholas Tan

  • Anthem Biosciences (1234D IN) is looking to raise up to US$397m in its upcoming India IPO. The deal will be run by JMF, Citi, JP Morgan and Nomura.
  • It is a Contract Research, Development, and Manufacturing Organization (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing.
  • As a one-stop service provider, ABS serves a range of customers, including innovator-focused emerging biotech companies and large pharmaceutical organizations globally.

GNA Axles (INE934S01014): Steady Q3FY25 Earnings, Major Expansion and Sustainability Push

By Sreemant Dudhoria

  • GNA Axles Ltd (GNA IN)  reported Q3FY25 results with Revenue/EBITDA/PAT growth of 5%, 11%, and 13%, respectively. The improvement in operating margin was driven by lower operating expenses.
  • In October 24, the company’s board approved a major capital expenditure program of INR 4 billion for manufacturing facilities and renewable energy.
  • The stock trades at an attractive valuation of 16x P/E for FY25 with 15% RoE and RoCE.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars